07:00 , Jul 15, 2013 |  BC Week In Review  |  Company News

Biolucidation LLC, Melior deal

Melior acquired all assets of CRO Biolucidation, which specialized in drug abuse liability studies. Melior said the acquisition significantly expands its preclinical pharmacology capabilities. Melior is using its theraTRACE system to develop an internal pipeline...